Navigation Links
UBC scientist honored with BMJ's Junior Doctor of the Year Award
Date:3/11/2010

BMJ Group, publisher of the British Medical Journal (BMJ), has recognized University of British Columbia Clinical Associate Prof. Evan Wood with its first annual Junior Doctor of the Year honour.

Wood, a lead researcher at the BC Centre for Excellence in HIV/AIDS (BC-CfE), was selected from more than 100 nominations from Britain, Sudan, Iraq, Australia and Brazil for his research in and contribution to HIV, public health, illicit drug policy and addiction. The award is given to a physician who is early in their career and has done the most to improve the world we live in or to inspire others.

As co-director of the BC-CfE's Urban Health Research Initiative (UHRI), Wood has early in his career established himself as a leading international authority on evidence-based approaches to addressing HIV among drug-addicted populations. Wood obtained his PhD in epidemiology studying the HIV epidemic in Vancouver's Downtown Eastside and authored more than 200 publications before the age of 30, including groundbreaking articles in leading medical journals such as BMJ, the Lancet and the New England Journal of Medicine.

Wood helped establish the UHRI and has received the Peter Lougheed Award as Canada's top-ranked new investigator by the Canadian Institutes of Health Research. He is one of the founding principal investigators of Vancouver's Insite, North America's only supervised injecting facility. His scientific and peer-reviewed evaluations of Insite have demonstrated that the program reduces overdose deaths, lowers HIV transmission rates, and increases uptake into addiction treatment. He now serves on the editorial boards of a host of infectious disease and addiction journals and is the associate editor of the International Journal of Drug Policy.

"I am honoured to accept this award on behalf of the people I work with at the BC-CfE, St. Paul's Hospital and UBC," said Dr. Wood. "BMJ Group recognizes the important role that research and science can play in shaping society's response to the illicit drug problem and related concerns. I am humbled by this recognition and would like to thank the colleagues I am honored to work with, the fantastic team of graduate students I am fortunate to supervise, and the participants in our research, who give willingly of their time and experiences."

While Dr. Wood has made key contributions to HIV treatment guidelines, his research into HIV prevention strategies for injection drug users has received international recognition. Dr. Wood is one of the founding principal investigators of Vancouver's Insite, North America's only supervised injecting facility. His scientific and peer-reviewed evaluations of Insite have demonstrated that the program reduces overdose deaths, lowers HIV transmission rates, and increases uptake into addiction treatment.

"Dr. Wood's passion for medicine and public health is evident in all the work that he does and the challenges that he takes on," said Dr. Julio Montaner, Director, BC-CfE. "He has tackled controversial subjects such as drug addiction with scientific rigour, and has often taken unpopular but scientifically sound positions on hot-button issues."

"Dr. Wood has made an exceptional contribution to improving healthcare by using the scientific results of his peer-reviewed research to elevate addiction, drug policy and diseases such as HIV to public health issues rather than criminal justice issues," said Dr. Fiona Godlee, Editor in Chief of the BMJ.

"Dr. Wood's work in Vancouver's Downtown Eastside and on facilities such as Insite illustrates the benefits of pursuing innovative and evidence-based approaches to improving treatment for addiction and diseases such as HIV and AIDS," said John Hepburn, UBC Vice-President Research & International.

"UBC is proud to support dedicated and respected researchers such as Dr. Wood who advance knowledge and challenge conventional thinking in these areas."


'/>"/>

Contact: Brian Lin
brian.lin@ubc.ca
604-822-2234
University of British Columbia
Source:Eurekalert

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... ... , ... Medical lab testing through hospitals and other traditional methods ... will take days to arrive to the end customer, having to travel through medical ... lab tests, bypassing the cost and delay of traditional means. Now all employees of ...
(Date:1/21/2017)... ... 2017 , ... Salveo for life, a company that distributes an effervescent lime-flavored ... States as part of its presence to expand its market reach. , Using a ... productions of nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, ...
(Date:1/21/2017)... (PRWEB) , ... January 21, 2017 , ... Seamild, the ... on the futuristic vision of its owner and founder. As Oat is recognized globally ... to everybody he knows personally as he believes it is a move to sow ...
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s ... electrifying line-up of events for its annual meeting “Coming Home 2017,” an activity-packed ... “Coming Home 2017” will be held on Friday January 27 through Sunday, January ...
(Date:1/21/2017)... ... January 21, 2017 , ... Santa Rosa ... in Petaluma, located at 167 Lynch Creek Way. The Petaluma office features three ... medicine and rehabilitation services and on-site x-ray services. Two multi-specialist orthopaedic surgeons ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017  Therabron Therapeutics, Inc., a clinical-stage ... in respiratory care, today announced that the European ... has granted Orphan Drug Designation for Therabron,s CG367 ... Syndrome (BOS).  "We are pleased to ... to treat patients diagnosed with BOS following lung ...
(Date:1/23/2017)... , Jan. 23, 2017 LifeVac, the ... a blocked airway and prevented choking deaths, welcomes ... advocate to the LifeVac team as Official Spokesperson. ... join the LifeVac team," said Arthur Lih , ... to represent LifeVac and his mission to raise awareness ...
(Date:1/23/2017)... 23, 2017 Research and Markets has announced the ... - Product - Forecast to 2025" report to their offering. ... Report Highlights: ... trends to identify the investment opportunities Market forecasts till ... Key market trends across the business segments, Regions and Countries ...
Breaking Medicine Technology: